215 related articles for article (PubMed ID: 31941083)
1. Glycine Cleavage System and cAMP Receptor Protein Co-Regulate CRISPR/
Yang D; Wang Z; Ma J; Fu Q; Wu L; Wang H; Wang S; Yan Y; Sun J
Viruses; 2020 Jan; 12(1):. PubMed ID: 31941083
[TBL] [Abstract][Full Text] [Related]
2. Cas3-stimulated runaway replication of modified ColE1 plasmids in Escherichia coli is temperature dependent.
Radovčić M; Čulo A; Ivančić-Baće I
FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31095294
[TBL] [Abstract][Full Text] [Related]
3. Cas3 is a limiting factor for CRISPR-Cas immunity in Escherichia coli cells lacking H-NS.
Majsec K; Bolt EL; Ivančić-Baće I
BMC Microbiol; 2016 Mar; 16():28. PubMed ID: 26956996
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the Type I-F CRISPR-Cas system by CRP-cAMP and GalM controls spacer acquisition and interference.
Patterson AG; Chang JT; Taylor C; Fineran PC
Nucleic Acids Res; 2015 Jul; 43(12):6038-48. PubMed ID: 26007654
[TBL] [Abstract][Full Text] [Related]
5. Cas3-Derived Target DNA Degradation Fragments Fuel Primed CRISPR Adaptation.
Künne T; Kieper SN; Bannenberg JW; Vogel AI; Miellet WR; Klein M; Depken M; Suarez-Diez M; Brouns SJ
Mol Cell; 2016 Sep; 63(5):852-64. PubMed ID: 27546790
[TBL] [Abstract][Full Text] [Related]
6. Repetitive DNA Reeling by the Cascade-Cas3 Complex in Nucleotide Unwinding Steps.
Loeff L; Brouns SJJ; Joo C
Mol Cell; 2018 May; 70(3):385-394.e3. PubMed ID: 29706536
[TBL] [Abstract][Full Text] [Related]
7. CasA mediates Cas3-catalyzed target degradation during CRISPR RNA-guided interference.
Hochstrasser ML; Taylor DW; Bhat P; Guegler CK; Sternberg SH; Nogales E; Doudna JA
Proc Natl Acad Sci U S A; 2014 May; 111(18):6618-23. PubMed ID: 24748111
[TBL] [Abstract][Full Text] [Related]
8. CRP represses the CRISPR/Cas system in Escherichia coli: evidence that endogenous CRISPR spacers impede phage P1 replication.
Yang CD; Chen YH; Huang HY; Huang HD; Tseng CP
Mol Microbiol; 2014 Jun; 92(5):1072-91. PubMed ID: 24720807
[TBL] [Abstract][Full Text] [Related]
9. Disabling a Type I-E CRISPR-Cas Nuclease with a Bacteriophage-Encoded Anti-CRISPR Protein.
Pawluk A; Shah M; Mejdani M; Calmettes C; Moraes TF; Davidson AR; Maxwell KL
mBio; 2017 Dec; 8(6):. PubMed ID: 29233895
[TBL] [Abstract][Full Text] [Related]
10. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3.
Gong B; Shin M; Sun J; Jung CH; Bolt EL; van der Oost J; Kim JS
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16359-64. PubMed ID: 25368186
[TBL] [Abstract][Full Text] [Related]
11. Clustered Regularly Interspaced Short Palindromic Repeat-Dependent, Biofilm-Specific Death of Pseudomonas aeruginosa Mediated by Increased Expression of Phage-Related Genes.
Heussler GE; Cady KC; Koeppen K; Bhuju S; Stanton BA; O'Toole GA
mBio; 2015 May; 6(3):e00129-15. PubMed ID: 25968642
[TBL] [Abstract][Full Text] [Related]
12. Easy regulation of metabolic flux in Escherichia coli using an endogenous type I-E CRISPR-Cas system.
Chang Y; Su T; Qi Q; Liang Q
Microb Cell Fact; 2016 Nov; 15(1):195. PubMed ID: 27842593
[TBL] [Abstract][Full Text] [Related]
13. GcvR interacts with GcvA to inhibit activation of the Escherichia coli glycine cleavage operon.
Ghrist AC; Heil G; Stauffer GV
Microbiology (Reading); 2001 Aug; 147(Pt 8):2215-2221. PubMed ID: 11495998
[TBL] [Abstract][Full Text] [Related]
14. Role for the leucine-responsive regulatory protein (Lrp) as a structural protein in regulating the Escherichia coli gcvTHP operon.
Stauffer LT; Stauffer GV
Microbiology (Reading); 1999 Mar; 145 ( Pt 3)():569-576. PubMed ID: 10217490
[TBL] [Abstract][Full Text] [Related]
15. A compact Cascade-Cas3 system for targeted genome engineering.
Csörgő B; León LM; Chau-Ly IJ; Vasquez-Rifo A; Berry JD; Mahendra C; Crawford ED; Lewis JD; Bondy-Denomy J
Nat Methods; 2020 Dec; 17(12):1183-1190. PubMed ID: 33077967
[TBL] [Abstract][Full Text] [Related]
16. A Tryptophan 'Gate' in the CRISPR-Cas3 Nuclease Controls ssDNA Entry into the Nuclease Site, That When Removed Results in Nuclease Hyperactivity.
He L; Matošević ZJ; Mitić D; Markulin D; Killelea T; Matković M; Bertoša B; Ivančić-Baće I; Bolt EL
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799639
[TBL] [Abstract][Full Text] [Related]
17. Helicase dissociation and annealing of RNA-DNA hybrids by Escherichia coli Cas3 protein.
Howard JA; Delmas S; Ivančić-Baće I; Bolt EL
Biochem J; 2011 Oct; 439(1):85-95. PubMed ID: 21699496
[TBL] [Abstract][Full Text] [Related]
18. Distinct Subcellular Localization of a Type I CRISPR Complex and the Cas3 Nuclease in Bacteria.
Govindarajan S; Borges A; Karambelkar S; Bondy-Denomy J
J Bacteriol; 2022 May; 204(5):e0010522. PubMed ID: 35389256
[TBL] [Abstract][Full Text] [Related]
19. Target DNA recognition and cleavage by a reconstituted Type I-G CRISPR-Cas immune effector complex.
Majumdar S; Ligon M; Skinner WC; Terns RM; Terns MP
Extremophiles; 2017 Jan; 21(1):95-107. PubMed ID: 27582008
[TBL] [Abstract][Full Text] [Related]
20. Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins.
Bondy-Denomy J; Garcia B; Strum S; Du M; Rollins MF; Hidalgo-Reyes Y; Wiedenheft B; Maxwell KL; Davidson AR
Nature; 2015 Oct; 526(7571):136-9. PubMed ID: 26416740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]